Hologic Inc. (HOLX) News
Filter HOLX News Items
HOLX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HOLX News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest HOLX News From Around the Web
Below are the latest news stories about HOLOGIC INC that investors may wish to consider to help them evaluate HOLX as an investment opportunity.
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025MARLBOROUGH, Mass., January 12, 2025--Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025 |
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to NoteIn the closing of the recent trading day, Hologic (HOLX) stood at $72.73, denoting a +0.05% change from the preceding trading day. |
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
HOLX Stock Gains Following the Acquisition of GynesonicsHologic completes the acquisition of Gynesonics, developer of the Sonata System, for approximately $350 million. |
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025MARLBOROUGH, Mass., January 06, 2025--Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 |
Hologic Completes Acquisition of Gynesonics, Inc.MARLBOROUGH, Mass., January 06, 2025--Hologic Completes Acquisition of Gynesonics, Inc. |
Hologic price target lowered to $76 from $81 at Evercore ISIEvercore ISI lowered the firm’s price target on Hologic (HOLX) to $76 from $81 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group. Published first on TheFly – the ultimate source for real-t |
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to KnowHologic (HOLX) concluded the recent trading session at $71.74, signifying a -0.49% move from its prior day's close. |
Here's Why You Should Retain HOLX Stock in Your Portfolio NowHologic's strength in the Surgical wing instills optimism among investors. Yet, currency impacts raise concerns. |
Hologic (HOLX) Flat As Market Sinks: What You Should KnowHologic (HOLX) closed at $72.68 in the latest trading session, marking no change from the prior day. |